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Catheter-associated urinary tract infections (CAUTIs) constitute the majority of nosocomial UTIs and pose
significant clinical challenges. Enterococcal species are among the predominant causative agents of CAUTIs.
However, very little is known about the pathophysiology of Enterococcus-mediated UTIs. We optimized a murine
model of foreign body-associated UTI in order to mimic conditions of indwelling catheters in patients. In this
model, the presence of a foreign body elicits major histological changes and induces the expression of several
proinflammatory cytokines in the bladder. In addition, in contrast to naïve mice, infection of catheter-
implanted mice with Enterococcus faecalis induced the specific expression of interleukin 1 (IL-1) and
macrophage inflammatory protein 1 (MIP-1) in the bladder. These responses resulted in a favorable niche
for the development of persistent E. faecalis infections in the murine bladders and kidneys. Furthermore,
biofilm formation on the catheter implant in vivo correlated with persistent infections. However, the entero-
coccal autolytic factors GelE and Atn (also known as AtlA), which are important in biofilm formation in vitro,
are dispensable in vivo. In contrast, the housekeeping sortase A (SrtA) is critical for biofilm formation and
virulence in CAUTIs. Overall, this murine model represents a significant advance in the understanding of
CAUTIs and underscores the importance of urinary catheterization during E. faecalis uropathogenesis. This
model is also a valuable tool for the identification of virulence determinants that can serve as potential
antimicrobial targets for the treatment of enterococcal infections.
Catheter-associated urinary tract infections (CAUTIs) are
the most common complications resulting from the use of
indwelling urinary catheters (25, 70). CAUTIs account for 40%
of all nosocomial infections (48) with more than one million
cases diagnosed annually in hospitals and nursing homes in the
United States, generating approximately $600 million in med-
ical expenditures every year (26, 69, 70). The pathophysiology
of CAUTIs results from the disruption of the normal mechan-
ical and antimicrobial defenses of the bladder and the injuries
ensuing from urinary catheterization, which render the bladder
environment vulnerable to microbial adhesion, multiplication,
and dissemination within the urinary tract (15, 47, 49, 51, 78).
Furthermore, indwelling urinary catheters provide an addi-
tional surface for microbial attachment and biofilm forma-
tion, which is a major component of the pathophysiology of
CAUTIs and other chronic device-associated persistent infections
(4, 6, 12, 14, 37, 46, 68). Once formed, biofilms provide a
favorable milieu for microbial survival within the host as the
organisms are shielded from the host immune response, as well
as antibiotics and antimicrobial agents (36, 67, 81), leading to
chronic or recurrent infections that are difficult to treat. If
untreated, CAUTIs can lead to more severe diseases such as
acute pyelonephritis, bacteremia, urosepsis, and in some cases,
death (38, 77). The high incidence of CAUTIs and their med-
ical and economic challenges underscore the need for a better
understanding of CAUTI pathogenesis.
While community-acquired UTIs are most commonly due to
uropathogenic Escherichia coli (UPEC), UPEC represent only
50% of bacterial isolates derived from patients with CAUTIs
(34). The Enterococcus species, especially Enterococcus faecalis
and Enterococcus faecium, account for 15% to 30% of CAUTIs
(38) and are now considered the third leading cause of hospi-
tal-acquired UTIs (20, 68). The ability of many enterococcal
isolates to produce biofilms (41, 60, 73) and the increasing
microbial resistance to antibiotics, including vancomycin, pose
significant challenges for the treatment of enterococcal infec-
tions (11, 80).
Several rodent models have been developed to study E.
faecalis pathogenesis in the urinary tract in single and mixed
infections with other Gram-negative pathogens (21, 29, 43, 61,
75). These models involve the transurethral inoculation of bac-
terial suspensions into the bladders of healthy animals or strep-
tozocin-induced diabetic animals (56) and have been shown to
be primarily useful for the study of E. faecalis-mediated pye-
lonephritis. The experimental conditions defined by these
models are inadequate for the investigation of persistent en-
terococcal CAUTI, since the bacteria are readily cleared from
the bladder and fail to establish chronic cystitis (29, 56, 61).
Nonetheless, data obtained from these models have implicated
some enterococcal factors in UTI pathogenesis, including the
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enterococcal surface protein Esp (61), the pilus-associated sor-
tase C (SrtC) (30), and the endocarditis and biofilm-associated
pilus (Ebp) (65). However, well-characterized adhesins and
biofilm determinants often associated with enterococcal UTI
isolates, like aggregation substance (AS) and the housekeeping
sortase A (SrtA) (17, 27, 33), were reported to be dispensable
for virulence in the urinary tract (27, 30). Since these conclu-
sions are drawn from models where persistent infections can-
not be established, it is imperative to reexamine the existing
paradigm in an animal model that better mimics the transition
of E. faecalis from a commensal organism to a virulent patho-
gen in the urinary tract.
In this study, we optimized a rodent model of foreign body-
associated UTI, developed in rats by Kurosaka et al. (35) and
adapted for mice by Kadurugamuwa et al. (28), to investigate
the pathophysiology of E. faecalis-mediated CAUTIs. We re-
port that the presence of silicone catheter implants causes
major physiological changes in the bladder, which becomes
predisposing to E. faecalis biofilm formation, and is associated
with persistent enterococcal cystitis and pyelonephritis. We
further demonstrate that biofilm formation on the silicone
implants and the development of successful enterococcal UTI
are independent of autolytic factors GelE and Atn, also known
as AtlA (13), but requires the presence of the housekeeping
sortase A (SrtA). Overall, this optimized murine model is well
suited to identify host and enterococcal factors critical for
pathogenesis in the urinary tract which will provide a better
understanding of the mechanisms underlying the pathophysi-
ology of CAUTIs.
MATERIALS AND METHODS
Bacterial strains and growth conditions. All strains used in this study and their
characteristics are listed in Table 1. Unless otherwise specified, Enterococcus
faecalis experiments were performed using an overnight culture grown in brain
heart infusion broth (BHI) (Becton Dickinson, Franklin Lakes, NJ) from a single
colony of E. faecalis grown on BHI agar plates supplemented with the appro-
priate antibiotics. Liquid cultures were grown statically at 37°C for 18 h. For E.
coli, bacteria from a single colony from a Luria-Bertani (LB) (Becton Dickinson)
agar plate were inoculated into LB broth, grown statically for 24 h, and subcul-
tured for another 24 h before use.
Mouse strain. Six- to 7-week-old female wild-type C57BL/6Ncr mice pur-
chased from the National Cancer Institute (NCI) were used in this study. Ex-
periments were performed following 1 week of adaptation in the animal facility.
All studies and procedures were approved by the Animal Studies Committee at
the Washington University School of Medicine.
Murine implantation procedure. The experimental model for foreign body-
associated UTI (28, 35) was adapted for the study of E. faecalis with the following
modifications. Polyethylene tubing (PE10 tubing with an outside diameter of 0.6
mm and inner diameter of 0.28 mm; Becton Dickinson, MD) and platinum-cured
silicone tubing (SIL025 tubing with an outside diameter of 0.64 mm and inside
diameter of 0.30 mm; Braintree Scientific, Inc., MA) were sterilized with 70%
ethanol and air dried. A 7-mm-long segment of PE10 tubing was fitted onto a
30.5-gauge sterile needle (Becton Dickinson). A 4- to 5-mm-long straight seg-
ment of SIL025 tubing was then placed on top of the PE10 segment. The
assembly was then UV sterilized for 24 h. Seven- to 8-week-old female wild-type
C57BL/6Ncr mice were anesthetized with inhaled isoflurane and placed on their
backs. The periurethral area was sterilized with 100% ethanol and 10% povidine-
iodine solution. The needle with both PE10 and SIL025 tubing was gently
inserted in the urethral opening. The long segment (PE10) was delicately ad-
vanced with tweezers until the shorter segment (SIL025) was released into the
bladder. Subsequently, the needle with the PE10 tubing was removed, leaving the
silicone implant in the murine bladder. The recovery of straight silicone implants
was greater than 95% at 24 h, and it was approximately 75% 7 days following
implantation (see Fig. S1 in the supplemental material).
Bacterial infection and CFU determination. Bacterial cells were collected
from overnight cultures by centrifugation at 8,000 g for 5 min and resuspended
in 1 phosphate-buffered saline (1 PBS) to an approximate optical density at
600 nm of 1 corresponding to approximately 7  108 CFU/ml. Seven- to eight-
week-old female C57BL/6Ncr mice with or without a silicone implant were
anesthetized by inhalation of isoflurane and infected by transurethral catheter-
ization as previously described (23, 44, 59) with 50-l inocula of PBS or bacterial
suspensions (2  107 to 3.5  107 CFU) immediately following implantation.
To quantify bacteria present on implants and in mouse organs, mice were sac-
rificed at desired time points by cervical dislocation after anesthesia inhalation,
and the bladders and kidneys were aseptically harvested. Subsequently, the
silicone implant was retrieved from the bladder when present, placed in 1 PBS,
sonicated for 10 min, and then vortexed at maximum speed for 3 min. The
bladder and both kidneys from each mouse were homogenized in 1 PBS. For
bacterial enumeration on implants and tissues, samples were serially diluted and
plated on BHI supplemented with the appropriate antibiotics or LB plates. CFU
were enumerated after 24 h of incubation at 37°C. Experiments were performed
at least twice with five mice per strain per condition.
Cytokine profiling. Bladder homogenates from animals with or without im-
plants and mock infected or infected with E. faecalis for 24 h were microcentri-
fuged at 14,000 rpm for 5 min, and supernatants were frozen at 80°C until the
time of the assay. Assays were carried out according to the manufacturer’s
protocols using the Bio-Plex Pro mouse cytokine 23-plex assay kit from Bio-Rad
Laboratories (Hercules, CA).
Histopathology and immunohistochemistry. For histological analyses, the
bladders were fixed in methacarn (60% methanol, 30% chloroform, and 10%
glacial acetic acid) for 1 to 2 h and dehydrated in 70% ethanol overnight at 4°C.
They were then embedded in paraffin, sectioned, and stained with hematoxylin
and eosin (H&E) for light microscopy. For immunofluorescence examination,
unstained bladder sections were deparaffinized with xylene (twice, for 10 min
each time), rinsed in 100% isopropanol (three times, for 5 min each time), and
washed with running deionized water for 5 min. This step was followed by a 1
PBS wash (three times for 5 min). The tissue sections were then blocked statically
in 5% fetal bovine serum in PBS (FBS-BB) for 30 min at room temperature.
Primary antibody raised in rabbit against Streptococcus group D antigen (Lee
Laboratories) and primary antibody raised in goat against mouse uroplakin III
(Santa Cruz Biotechnology, Inc., Santa Cruz, CA) were added to FBS-BB at
1:1,000 and 1:500 dilutions, respectively, and incubated at room temperature for
1 h. After a 5-min PBS wash (three times, for 5 min each time), tissue sections
TABLE 1. Bacterial strains used in this study
Bacterial strain Relevant antibioticresistancea Description Reference
E. faecalis strains
OG1RF (wild type) Rif25 Fus25 Parental OG1RF strain 16
OG1RFatn Rif25 Fus25 Strain OG1RF with an in-frame deletion of atn 16
OG1RFsrtA Rif25 Fus25 OG1RF with an in-frame deletion of srtA 16
OG1RFsrtAc Rif25 Fus25 Kan500 Complemented strain OG1RFsrtA expressing a wild-type
copy of srtA from the rofA promoter on pABG5
16
OG1RFgelE Rif25 Fus25 OG1RF with an in-frame deletion of gelE 70
E. coli UTI89 Uropathogenic E. coli cystitis isolate 44
a The superscript numbers indicate the concentrations (in g/ml) of antibiotics to which the strains are resistant. Rif, rifampin; Fus, fusidic acid; Kan, kanamycin.
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were incubated with Alexa Fluor 555-labeled donkey anti-rabbit antibody and
Alexa Fluor 488-labeled donkey anti-goat antibody, each diluted 1:1,000 in
FBS-BB for 30 min at room temperature. After the tissues were washed with PBS
(once for 5 min), they were counterstained with TOPRO-3 (Molecular Probes,
Eugene, OR) at 1:1,000 dilution in 1 PBS (second wash for 5 min) to reveal
nuclear morphology. After a third PBS wash for 5 min, immunostained tissues
were mounted using Prolong Gold Antifade (Molecular Probes) and visualized
by immunofluorescence microscopy (IFM). IFM was performed with an LSM
510 Meta laser scanning confocal microscope (Carl Zeiss, Thornwood, NY)
using a 63 oil immersion objective. Images were acquired using the LSM Image
Examiner software (Carl Zeiss, Thornwood, NY).
Scanning electron microscopy. Retrieved silicone implants were fixed in 4%
paraformaldehyde, 2.5% glutaraldehyde, and 0.1 M cacodylate and prepared for
scanning electron microscopy (Hitachi Ltd., Tokyo, Japan).
Statistical methods. Comparisons among groups were conducted by the
Mann-Whitney U test using GraphPad Prism (GraphPad software, version 4.03).
Values below the limit of detection (LOD) (40 or 20 CFU for organs and 80 CFU
for implants) were assigned the appropriate LOD value for statistical analyses.
All tests were two tailed, and a P value of less than 0.05 was considered signif-
icant. Colonization and infection were defined as organs/implants with bacterial
titers above the limit of detection at 24 hours postinfection (hpi).
RESULTS
E. faecalis establishes persistent infections in the bladders
and kidneys in an optimized murine model of CAUTI. In order
to study the pathophysiology of E. faecalis-mediated CAUTI,
we introduced 4- to 5-mm-long pieces of silicone tubing into
the bladders of C57BL/6Ncr female mice. Silicone is a com-
mon material used in Foley catheters in humans (18, 57).
Following catheter implantation, mice were immediately in-
fected with 2  107 to 3.5  107 CFU of E. faecalis strain
OG1RF by transurethral catheterization. In mock infection
studies with phosphate-buffered saline (PBS), no bacteria were
recovered from implants or organs (data not shown). Twenty-
four hours after animals with implants were infected with
strain OG1RF, bacteria were recovered from the implants at a
median value of 9.76  105 CFU (Fig. 1A). Bacterial titers on
the abiotic surfaces increased significantly over the course of
the infection (7 days) to a median value of 8.64 106 CFU/ml.
In animals with implants, strain OG1RF reaches a median titer
of 3.2  106 CFU/ml 24 hpi in the bladders, which is signifi-
cantly higher (P  0.0011) than bacterial titers (2.7  103
CFU/ml) recovered from the bladders of animals with no im-
plants (Fig. 1B). Similarly, bacterial titers from the kidneys
increased significantly from 24 hpi to 7 days postinfection (dpi)
in implanted animals (Fig. 1C). E. faecalis OG1RF was readily
cleared from the bladders and the kidneys within 48 hpi in the
absence of implants (Fig. 1B and C). In addition, bacterial
titers were significantly lower in tissues derived from animals
that lost their implants during the course of infection than in
tissues from animals where the implants were retrieved (Fig.
2), with the exception of bladder titers at 48 hpi (P  0.0737)
and kidneys titers at 72 hpi (P  0.130). These data suggest
that the presence of the implants contributes to increased
bacterial colonization and persistence in the urinary tract. In
contrast, bladder implants did not enhance the colonization of
uropathogenic E. coli UTI89 strain, a well-studied isolate from
a human with cystitis (45) and with strong tropism to the
bladder (see Fig. S2 in the supplemental material).
Implanting tubing into the bladder induces histological and
immunological changes in the murine bladder. Urinary cath-
eterization causes disruption of the protective layers of the
uroepithelium and causes histological changes (16, 51). In an-
imals with implants, both infected and mock-infected blad-
ders were edematous, distended, and sometimes hemorrhagic
throughout the experimental period (data not shown). Com-
pared to mock-infected bladders without implants (Fig. 3A and
D), mock-infected bladders with implants revealed mucosal
hyperplasia, submucosal edema with polymorphonuclear leu-
kocyte (PMN) infiltration into the lamina propria and epithe-
lium, as well as urothelial sloughing at 24 hpi (Fig. 3B and E).
The histology of the uroepithelium following infection of im-
planted bladders with E. faecalis OG1RF was similar to that of
FIG. 1. E. faecalis establishes persistent colonization of silicone
implants, bladders, and kidneys in a murine model of CAUTI.
(A) Bacterial titers in logarithmic scale (log scale) from silicone im-
plants retrieved from female C57BL/6Ncr mice infected with OG1RF
for 24, 48, and 72 hpi (1, 2, and 3 dpi) and 7 dpi. (B and C) Graphs
represent bacterial titers from homogenized bladders (B) and kidneys
(C) from animals without implants () (E) or animals with implants
() (F) infected with strain OG1RF for 1, 2, 3, or 7 dpi. In panels A
to C, the horizontal broken line represents the limit of detection for
viable bacteria. Each symbol represents the value for an individual
mouse from two independent experiments with five mice for each
condition. The horizontal bar represents the median value for each
group of mice. Values that are significantly different by the Mann-
Whitney U test are indicated as follows: *, P  0.05; **, P  0.005;
***, P  0.0005. Values that are not significantly different (ns) by the
Mann-Whitney U test are indicated.




arch 26, 2014 by W







mock-infected implanted animals (Fig. 3C and F). In contrast,
nonimplanted bladders infected with strain OG1RF showed no
major histological changes and appeared similar to the blad-
ders of mock-infected nonimplanted animals (data not shown)
as has been shown previously with other E. faecalis strains (29).
Damage to the uroepithelium in bladders with implants
could also be observed by immunofluorescence microscopy
using anti-uroplakin III antibody, which stains the luminal sur-
face of the terminally differentiated superficial umbrella cells
of the bladder. Comparison of bladder sections at 24 hpi
showed discontinuity of uroplakin staining of bladders with
implants (Fig. 3H) versus continuous epithelial staining of
bladders without implants (Fig. 3G), indicating the loss of
superficial umbrella cells in the former. Using an antibody
against the Lancefield streptococcal group D antigen to stain
the enterococcal organisms in histology sections, we found
bacterial staining in the bladder lumen of infected animals with
implants. The bacteria were found in association with the sur-
face of the uroplakin-positive and uroplakin-negative uroepi-
thelium and occasionally found in the submucosal areas (Fig.
3I; see Fig. S3 in the supplemental material). In contrast, very
few bacteria were observed in the bladders of nonimplanted
animals 24 hpi (data not shown). No labeling was observed in
mock-infected animals with or without implants (Fig. 3G and
H), reaffirming the specificity of the antibody staining. These
data suggest that implantation with a foreign body elicits major
architectural changes in the bladder associated with activation
of the host immune response, which predisposes the bladder to
enterococcal colonization.
Implantation leads to the upregulation of specific inflam-
matory markers in the murine bladder. To investigate how the
host immune status is altered in the presence of a foreign body,
we analyzed the levels of expression of 23 cytokines from
whole-bladder homogenates from mice with and without im-
plants after the mice were inoculated with PBS or E. faecalis
OG1RF. Of the 23 cytokines examined, only interleukin 6
(IL-6), granulocyte colony-stimulating factor (G-CSF), and ke-
ratinocyte-derived cytokine (KC) were consistently expressed
in implanted animals at least 2-fold above the levels of non-
implanted mock-infected (PBS-inoculated) animals at 24 hpi
(Fig. 4). Conversely, granulocyte-monocyte colony-stimulating
factor (GM-CSF) and macrophage inflammatory protein 1	
(MIP-1	) showed at least twofold decreased expression in im-
planted animals compared to nonimplanted animals 24 hpi
(Fig. 4). E. faecalis infection of the implanted animals slightly
enhanced the expression of IL-6, IL-12(p40), G-CSF, and KC
and specifically induced the expression of IL-1
 and MIP-1	 in
implanted animals compared to implanted mock-infected an-
imal controls (Fig. 4). E. faecalis OG1RF infection of nonim-
planted animals resulted in no significant changes in the ex-
pression of the cytokines tested compared to mock infection
(see Fig. S4 in the supplemental material). These findings
indicate that the silicone implant elicits a specific inflammatory
response in the bladder that is enhanced upon bacterial chal-
lenge with strain OG1RF.
E. faecalis produces biofilm on the surface of the silicone
implant in vivo. To determine whether bacteria recovered from
silicone implants are within biofilms, we examined 15 implants
retrieved 72 hpi from murine bladders from three independent
experiments by scanning electron microscopy (SEM). The im-
plants from mock-infected mice were coated on the outside
and in the lumen with host factors found in the urine as pre-
viously reported (58; data not shown). A similar appearing film
was also observed on 12 implants retrieved from animals in-
fected with E. faecalis OG1RF. In approximately 70% of the
silicone implants retrieved from infected animals, bacteria
were readily observed in clumps both on the outer surface (Fig.
5A and B) or filling the entire lumen (Fig. 5C to F). The
coccoid microorganisms were observed embedded in what ap-
peared to be an extracellular matrix (Fig. 5E and F). The
reason for the absence of biofilms from the remaining implants
is not certain, but it could be due to sample processing prior to
visualization, since those animals also exhibited significantly
enhanced infection. These findings indicate that enterococcal
biofilms are produced in vivo on indwelling silicone material
during the course of the infection.
E. faecalis biofilm formation and virulence in the urinary
tract occur independently of autolytic factors but require sor-
tase A. E. faecalis biofilm production on abiotic surfaces in vitro
has been shown to depend in part on the autolytic factors GelE
and Atn as well as the housekeeping sortase SrtA (17, 33, 71).
Thus, we created in-frame deletions in each of these genes and
FIG. 2. Implant loss from murine bladders correlates with less severe infection of the bladder and kidney. Graphs represent bacterial titers in
log scale recovered from the bladders (A) and kidneys (B) of animals that have lost the implants (L) (E) or retained the implants (R) (F) at the
indicated time of sacrifice. The experiment was done at least three times with five mice in each experiment. The horizontal broken line depicts the
limit of detection. The horizontal bar represents the median value for each group of mice. Values that are significantly different by the
Mann-Whitney U test are indicated as follows: *, P  0.05; **, P  0.005; ***, P  0.0005. Values that are not significantly different (P  0.05)
(ns) by the Mann-Whitney U test are indicated.
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tested their virulence in the CAUTI model. When introduced
into animals with implants, E. faecalis OG1RFgelE colonized
the implants, bladders, and kidneys as well as or better (sig-
nificant increase in implant titers; P  0.0279) than the paren-
tal strain OG1RF 24 hpi (Fig. 6A to C). The absence of the
major autolysin Atn did not alter the colonization of implants
or urinary tissues relative to the wild-type strain (Fig. 6D to F).
Moreover, strain OG1RFatn was able to persist in the blad-
der and kidney tissues (see Fig. S5 in the supplemental mate-
rial) and on the implants (Fig. 6D) as well as the wild-type
OG1RF strain did (Fig. 6D). However, infection of implanted
mice with a previously characterized srtA-deficient OG1RF
strain (OG1RFsrtA) caused a 105 decrease in bacterial titers
recovered from the implants (Fig. 7A) and an approximately
103 decrease in CFU recovered from both bladders and kid-
neys compared to infection with the wild-type strain (Fig. 7B
and C). Infecting mice with implants with OG1RFsrtAc, a
complemented strain ectopically expressing a wild-type copy of
srtA, partially rescued wild-type colonization levels of implants
and organs (Fig. 7A to C). The lack of full complementation is
not entirely understood, but it may be due to plasmid loss
during infection based on higher colony counts in the absence
of antibiotic. Similar findings were observed at 48 hpi (data not
shown). Electron microscopic examination of the implants re-
vealed very few OG1RFsrtA cells present on the surface or in
the lumen of retrieved implants 72 hpi in contrast to the com-
plemented, atn-deficient, and wild-type strains that heavily col-
onized the implants (Fig. 7D). Comparable results were ob-
tained when biofilms were grown in vitro in human urine under
fluid flow (data not shown). These results indicate that unlike
GelE and Atn, SrtA or more specifically, a SrtA-dependent
substrate(s) is critical for biofilm production and virulence in
the urinary tracts of animals with implants.
DISCUSSION
Enterococci, normally commensal bacteria of the human
oral cavity and gastrointestinal tract, have become important
opportunistic pathogens in hospital settings. While not histor-
ically regarded as an important uropathogen in uncomplicated
FIG. 3. Implantation-mediated histological changes are associated with enterococcal colonization of the murine bladder. (A to F) H&E staining
of bladder sections derived from animals without implants inoculated with PBS (A and D), animals with implants inoculated with PBS (B and E),
or animals with implants infected with E. faecalis OG1RF (C and F) 24 hpi observed with a light microscope at magnifications of 40 (A to C)
and 63 (D to F). Areas in black boxes on panels A, B, and C are magnified in panels D, E, and F, respectively. Severe edema, hyperplasia,
urothelial sloughing, and immune cell infiltration characterize bladders of implanted animals with or without bacterial challenge. The white arrow
in panel E indicates damage to the uroepithelium. Abbreviations: U, uroepithelium; LP, lamina propria; L, lumen; M, muscularis. (G to I) Representative
laser scanning confocal microscopic (CLSM) images of bladder sections from PBS-treated nonimplanted, PBS-treated implanted, and OG1RF-infected
implanted mice 24 hpi immunolabeled with goat anti-mouse uroplakin III (green), rabbit anti-Lancefield group D antigen (red), and counterstained with
TOPRO-3 nuclear dye (blue) reveal alterations to the uroepithelium of implanted bladders and the presence of bacteria in the bladder lumen and on
the uroepithelial surface. The white broken line separates the lumen (L) from the uroepithelium surface (U). Bars  10 m.
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community-acquired cystitis, E. faecalis is now considered a
major agent of hospital-acquired UTIs where catheterization
and indwelling medical devices can negatively impact patients’
defenses against pathogens (20). However, the lack of a robust
animal model of enterococcal UTI has impeded the study of
this pathogen within the urinary tract. In previously established
models of ascending UTIs, E. faecalis fails to establish persis-
tent bladder colonization and primarily displays tropism to the
kidneys (21, 29, 43, 56, 61, 75). The absence of persistent
infections in these murine models reflects the profile of E.
faecalis in community-acquired UTIs where this bacterium
represents less than 5% of clinical isolates (55). As an oppor-
tunistic pathogen, E. faecalis requires changes in bladder ho-
meostasis following urinary catheterization in order to achieve
successful infection of the urinary tract.
In this study, we investigated the pathophysiology of E. fae-
calis-mediated CAUTIs using a murine model of foreign body-
associated UTI that was modified from previous studies (28,
35). Our results indicate that the presence of silicone tubing in
the murine bladder elicits histopathological and immunologi-
cal changes that are similar to the effects seen in patients with
spinal cord injuries and postsurgical patients with indwelling
urinary catheters (8, 16, 51, 76). Furthermore, we show that E.
faecalis forms biofilms on the silicone implants and is able to
persist at high titers in the bladders and kidneys of animals
with implants.
The striking difference in bladder colonization and virulence
from previous models is a direct consequence of implantation,
which provides an abiotic surface for biofilm production. Bio-
films have been implicated in the establishment of chronic
infections, including CAUTIs (6, 74). Our data indicate that
biofilm production on the surface of the implants is associated
with persistent enterococcal cystitis. Bacteria within biofilms
may continuously seed the bladder, preventing effective clear-
ance by the host and leading to persistent cystitis.
Atn (17, 71) and GelE (52, 71, 72) have been shown to be
important in E. faecalis biofilm formation. Atn has been shown
to be a mediator of autolysis and DNA release, facilitating
attachment to abiotic surfaces, thus promoting biofilm forma-
tion in vitro (17, 33, 41, 53). The extracellular protease GelE (1,
39) and the serine protease (SprE) mediate Atn-dependent
DNA release during enterococcal biofilm formation (71, 72).
GelE has been associated with virulence in several models of
infection (19, 22, 52, 62, 66). When introduced into mice with
silicone implants to assess their contribution to CAUTI, both
atn- and gelE-deficient mutants were as virulent as the wild-
type strain. Thus, under these conditions, urinary tract coloni-
zation and biofilm formation on the implant did not require
Atn or GelE. While these factors are important determinants
of DNA-dependent biofilm production in vitro, the ability of E.
faecalis to colonize the implants and promote infection in the
absence of both Atn and GelE argues that extracellular DNA
may not be an important contributor of the extracellular matrix
of enterococcal biofilms in vivo in the urinary tract or that its
release may occur in an Atn/GelE-independent manner. Con-
sistent with this finding was the observation that gelatinase was
not expressed in 71/163 clinical isolates (42) of E. faecalis, and
the presence of gelE did not correlate with gelatinase expres-
FIG. 4. Implantation and E. faecalis infection elicit the production
of specific cytokines in the bladder. Graphs represent cytokine expres-
sion in the whole bladder of animals with implants inoculated with PBS
or E. faecalis OG1RF at 24 hpi. Cytokines reported are expressed with
at least twofold difference relative to mock-infected animals with no
implants. The presence of implants induces the specific expression of
IL-6, G-CSF, and KC and causes the downregulation of GM-CSF and
MIP-1	. In contrast, E. faecalis elicits the specific expression of IL-1
,
IL-12(p40), and MIP-1	 at 24 hpi. Data represent a representative
experiment performed four times with five mice for each condition in
the experiment. Values are shown as the means plus standard errors of
the means (error bars). Values that are significantly different (P 0.05
by the Mann-Whitney U test) are indicated (*).
FIG. 5. E. faecalis produces biofilms on the surfaces of silicone
implants in vivo. Representative scanning electron micrographs of sil-
icone implants retrieved from murine bladders infected with E. faecalis
OG1RF at 72 hpi showing bacterial biofilms on the outer surface (A
and B) and filling the lumen (C and F) of the silicone implant. Bacteria
(white arrowhead) are often associated with host cells, indicated by the
black arrowhead in panel C. Both bacteria and host immune cells can
also be found embedded in a thick extracellular material, indicated by
the black arrow, in the lumen of the silicone implant 72 hpi (E and
F). Areas in black boxes on panels A, C, and E are magnified in
panels B, D, and F, respectively. Bars, 20 m (A and C), 5 m (B,
D, and F), and 100 m (E).
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sion (7) or their ability to form biofilms in vitro (42). However,
a recent study by Arciola et al. (1) found a correlation with a
high level of expression of GelE and the ability to form biofilms
in enterococci from orthopedic implant infections, indicating
that the factors utilized by enterococci in forming biofilms may
depend on the substrate and/or site of infection. Identification
of the major components of the extracellular matrix of in vivo
enterococcal biofilms will lead to a better understanding of
CAUTIs and will be of valuable interest for designing thera-
peutics that promote the prevention and disruption of these
structures.
Sortases have also been implicated in enterococcal biofilm
production (17, 30, 33). Recent studies have shown that SrtA,
a transpeptidase that anchors LPXTG-containing surface pro-
teins to the cell walls of Gram-positive bacteria (40), plays a
major role during in vitro biofilm development (17, 30, 33).
Deletion of srtA in E. faecalis prevented adherence and subse-
quent biofilm growth on abiotic surfaces (17). Although Kemp
et al. (30) reported that disruption of srtA did not significantly
affect virulence in a murine model of ascending UTI, our data
reveal that SrtA is critical in the establishment of CAUTI. The
srtA-deficient mutant is unable to colonize the implants in vivo
and is significantly attenuated in CAUTI. These findings fur-
ther underscore the importance of biofilm production during
E. faecalis pathogenesis and strongly suggest that SrtA-depen-
dent substrates may be required for attachment to abiotic
surfaces and/or to damaged uroepithelium in vivo during the
establishment of infection. It will be of interest to identify
SrtA-dependent substrates that are critical in CAUTI. For
example, surface proteins known as MSCRAMMs (microbial
surface components recognizing adhesive matrix molecules)
have been identified in E. faecium and E. faecalis (50, 63, 64).
MSCRAMMs, some of which are putative SrtA-dependent
substrates, can bind to host cells via interactions with host
extracellular matrix proteins such as collagen and fibrinogen.
The disruption of urothelial surfaces, as the result of catheter-
ization, may expose factors that SrtA-dependent substrates,
such as MSCRAMMs, can recognize to promote attachment
and colonization.
Additionally, catheter-mediated abrasions to bladder epithe-
FIG. 6. Autolytic factors are not required for E. faecalis virulence in the urinary tract. (A to F) Graphs show the numbers of CFU of E. faecalis
OG1RF and isogenic in-frame gelE- and atn-deficient mutants recovered from retrieved implants (A and D), bladders (B and E), and kidneys (C
and F) from animals 24 hpi following infection with either strain. Horizontal dashed lines represent the limits of detection for viable bacteria. Each
symbol represents the value for an individual mouse, and each experiment was done twice with four or five mice for each strain. Only data from
animals with implants at the time of sacrifice are represented. The horizontal bars indicate the median values for groups. Values that are
statistically significantly different (P  0.05) by the Mann-Whitney U test are indicated (*). Values that are not statistically significantly different
(P  0.05) by the Mann-Whitney U test are indicated (ns).
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lial cells have been previously shown to induce the production
of lactate dehydrogenase and small amounts of IL-6 and IL-8
(2). In this report, we also show that the presence of these
implants elicits the expression of specific inflammatory markers in
the bladders, including granulocyte colony-stimulating factor (G-
CSF), keratinocyte-derived cytokine (KC) or CXCL1 (chemo-
kine [C-X-C motif] ligand 1), and IL-6, whereas GM-CSF and
MIP-1	 (chemokine [C-C motif] ligand 3 [CCL3]) expression
was decreased. All the above cytokines are produced by mac-
rophages, neutrophils, and epithelial cells and are important in
the recruitment of PMNs and other immune cells to sites of
infection (3, 5, 31, 32, 54). The presence of E. faecalis in
animals with implants specifically elicits the production of
IL-1
 and MIP-1	 during CAUTI. These cytokines, produced
by neutrophils and other immune cells, are important media-
tors of the inflammatory response to microbial infections (5,
9). In particular, IL-1
 was shown to be released during
UPEC-mediated acute cystitis (24). The CAUTI model will be
useful in unraveling the balance and interplay between inflam-
mation and bacterial colonization and persistence.
The efficient bacterial clearance and the significantly lower
titers recovered from the urinary tracts of mice without im-
plants and/or with the loss of implants further corroborate the
importance of a foreign body in bacterial persistence. Further-
more, our results indicate that the presence of a silicone im-
plant in the bladder allows E. faecalis to successfully ascend to
the kidneys and establish persistent infection in animals with
implants. The onset of acute pyelonephritis has also been re-
ported in postmortem studies of the elderly with indwelling
catheters at the time of death (79). In the clinical setting, the
removal of infected indwelling urinary catheters is one of
the most effective methods used to resolve bacteriuria and
CAUTIs (74, 78). However, removing the indwelling medical
device, even combined with long course of antibiotic treatment
(74), may not be sufficient for complete resolution of the in-
fection, especially with the rise in antibiotic resistance ob-
served in nosocomial settings (11, 20). In addition, implant
removal upon infection in other device-associated infections
like prosthetic valve endocarditis is not in itself efficacious (10,
12) and thus may not be a suitable therapeutic approach in all
instances. Understanding the pathogenesis of CAUTIs may
lead to new and better ways to treat and prevent these diseases.
The optimized murine model of foreign body-associated
UTI presented here is highly relevant for the investigation of
the mechanisms underlying Enterococcus-mediated CAUTIs,
since it couples biofilm production to enterococcal virulence
during E. faecalis uropathogenesis. This murine model is a
valuable and robust tool in the identification and character-
ization of novel biofilm determinants and bacterial virulence
factors and host responses pertinent to the pathogenesis of
E. faecalis in the urinary tract and the mechanisms under-
lying enterococcal ascension to the kidneys. Importantly,
our optimized model will serve as an ideal platform for
testing potential therapeutics against enterococcal infec-
tions and antibiofilm compounds.
FIG. 7. Sortase A is critical for implant colonization and virulence in the urinary tract. (A to C) Graphs show bacterial titers from implants (A),
homogenized bladders (B), and kidneys (C) from mice with implants infected for 24 h with E. faecalis OG1RF (wild type [WT]) (F), OG1RFsrtA
(), or OG1RFsrtAc (f). Thick horizontal broken lines represent the limits of detection for viable bacteria. Each symbol is the value for an
individual mouse, and each experiment was done at least twice with five mice for each strain. Only data from animals with implants at the time
of sacrifice are represented. The horizontal bar indicates the median value for each group of mice. Values that are statistically significantly different
by the Mann-Whitney U test are indicated as follows: *, P  0.05; **, P  0.005; ***, P  0.0001. Values that are not statistically significantly
different (P  0.05) by the Mann-Whitney U test are indicated (ns). (D) Representative scanning electron micrographs of silicone implants
retrieved from murine bladders 72 hpi with E. faecalis OG1RF (WT), OG1RFsrtA, OG1RFsrtAc, and OG1RFatn showing massive bacterial
colonization for the wild type and atn-deficient mutant, but very few OG1RFsrtA cells are present in the lumen of the implants. Bars, 5 m for
strains OG1RF (WT), OG1RFsrtA, and OG1RFsrtAc and 2.5 m for strain OG1RFatn.
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